Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Solara Active Pharma Sciences has informed that the Board of Directors of the Company at their meeting held today, February 06, 2026, have considered and approved the following matters: 1. Amended the ‘Policy for Determining Materiality of Events / Information for Disclosure to Stock Exchanges’ in line with the amendments in Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015. The amended Policy is available on the Company’s website at solara.co.in/investor-relations/policies-and-guidelines/. 2.The Members of the Board has reviewed and adopted the revised ‘Policy for Governance of Related Party Transactions’ in compliance with amendment to the Regulation 23 of SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015 and any amendments thereto. The amended Policy is available on the Company’s website at solara.co.in/investor-relations/policies-and-guidelines/.
The above information is a part of company’s filings submitted to BSE.
